These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 20155998

  • 1. Olanzapine/fluoxetine: a review of its use in patients with treatment-resistant major depressive disorder.
    Croxtall JD, Scott LJ.
    CNS Drugs; 2010 Mar; 24(3):245-62. PubMed ID: 20155998
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine/fluoxetine: a review of its use in the treatment of acute bipolar depression.
    Deeks ED, Keating GM.
    Drugs; 2008 Mar; 68(8):1115-37. PubMed ID: 18484802
    [Abstract] [Full Text] [Related]

  • 3. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA, Williamson D, Sanger TM, Briggs SD, Case M, Tollefson G.
    Depress Anxiety; 2006 Mar; 23(6):364-72. PubMed ID: 16710853
    [Abstract] [Full Text] [Related]

  • 4. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
    Shelton RC, Williamson DJ, Corya SA, Sanger TM, Van Campen LE, Case M, Briggs SD, Tollefson GD.
    J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
    [Abstract] [Full Text] [Related]

  • 5. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME, Corya SA, Osuntokun O, Case M, Henley DB, Sanger TM, Watson SB, Dubé S.
    J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
    [Abstract] [Full Text] [Related]

  • 6. Spotlight on olanzapine/fluoxetine in acute bipolar depression.
    Deeks ED, Keating GM.
    CNS Drugs; 2008 Feb; 22(9):793-5. PubMed ID: 18698877
    [Abstract] [Full Text] [Related]

  • 7. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    Amsterdam JD, Shults J.
    J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine/fluoxetine combination for bipolar depression and other mood disorders: a review.
    Owen RT.
    Drugs Today (Barc); 2006 Mar; 42(3):185-92. PubMed ID: 16628260
    [Abstract] [Full Text] [Related]

  • 9. The combination of olanzapine and fluoxetine in mood disorders.
    Shelton RC.
    Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
    [Abstract] [Full Text] [Related]

  • 10. Long-term weight gain in patients treated with open-label olanzapine in combination with fluoxetine for major depressive disorder.
    Andersen SW, Clemow DB, Corya SA.
    J Clin Psychiatry; 2005 Nov; 66(11):1468-76. PubMed ID: 16420086
    [Abstract] [Full Text] [Related]

  • 11. Economic impact of olanzapine plus fluoxetine combination therapy among patients treated for depression: a pilot study.
    Corey-Lisle PK, Birnbaum H, Greenberg P, Marynchenko M, Dube S.
    Psychopharmacol Bull; 2003 Nov; 37(3):90-8. PubMed ID: 14608242
    [Abstract] [Full Text] [Related]

  • 12. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA, Perlis RH, Keck PE, Lin DY, Case MG, Williamson DJ, Tohen MF.
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [Abstract] [Full Text] [Related]

  • 13. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH, Thase ME, Osuntokun O, Henley DB, Case M, Watson SB, Campbell GM, Corya SA.
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [Abstract] [Full Text] [Related]

  • 14. Efficacy, safety and tolerability of Symbyax for acute-phase management of treatment-resistant depression.
    Bobo WV, Shelton RC.
    Expert Rev Neurother; 2010 May; 10(5):651-70. PubMed ID: 20420487
    [Abstract] [Full Text] [Related]

  • 15. Olanzapine/Fluoxetine (Symbyax) for bipolar depression.
    Med Lett Drugs Ther; 2004 Mar 15; 46(1178):23-4. PubMed ID: 15037858
    [No Abstract] [Full Text] [Related]

  • 16. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC, Frankenburg FR, Parachini EA.
    J Clin Psychiatry; 2004 Jul 15; 65(7):903-7. PubMed ID: 15291677
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
    Tohen M, Case M, Trivedi MH, Thase ME, Burke SJ, Durell TM.
    J Clin Psychiatry; 2010 Apr 15; 71(4):451-62. PubMed ID: 20361905
    [Abstract] [Full Text] [Related]

  • 18. A novel augmentation strategy for treating resistant major depression.
    Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, Feldman PD, Meltzer HY.
    Am J Psychiatry; 2001 Jan 15; 158(1):131-4. PubMed ID: 11136647
    [Abstract] [Full Text] [Related]

  • 19. Treatment of bipolar depression: making sensible decisions.
    Citrome L.
    CNS Spectr; 2014 Dec 15; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [Abstract] [Full Text] [Related]

  • 20. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 15; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.